MDGL vs PEP · rev $675.6M vs P/E 22, rev $43.62B
Madrigal Pharmaceuticals Inc (MDGL) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
MDGL currently screens at market cap $11.56B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the MDGL and PEP stock pages for the full models.
Not investment advice.